| NexMed, Inc. Q1 2010 Earnings Call Transcript NexMed, Inc. (NEXM)Q1 2010 Earnings CallMay 14, 2010 12:00 pm ETComplete Story » seekingalpha.com |
MEDTOX Scientific Announces Strong Second Quarter Results (GlobeNewswire) ST. PAUL, Minn. -- MEDTOX Scientific, Inc. today announced results for the second quarter ended June 30, 2010. MEDTOX achieved a significant increase in new clinical laboratory business for the quarter ended June 30, 2010, and laboratory drugs-of-abuse testing showed a net positive increase in revenues of 5.6% for the second quarter of 2010, compared to a decrease of 10.6% in the prior year quarter: us.rd.yahoo.com |
Bid to Revive 9/11 Health-Care Bill New York lawmakers have begun discussing ways of rescuing a bill to provide health care for ill Ground Zero workers following its defeat on the House floor last week after a bitter battle. online.wsj.com |
10 Year-End Stock Trades on FDA Binary Events Mike Havrilla submits:Below is a selection of 10 companies with pending FDA decisions or Advisory Panel meetings that are expected through year-end as a follow-up to my article published two weeks ago, highlighting 190 stocks with FDA decisions expected through the end of October. 1.) MannKind (NASDAQ:MNKD) $6.06, $799 million (M) market capComplete Story » seekingalpha.com |
Blood-Transfusion Risks in Heart Patients Two new studies suggest that blood transfusions often provide little benefit—and may increase health risks—to heart-surgery patients online.wsj.com |